SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Atlantic(ATLC), a new twist to antisense -- Ignore unavailable to you. Want to Upgrade?


To: Greg Rich who wrote (5)2/6/1999 9:05:00 AM
From: notyet  Read Replies (1) | Respond to of 22
 
Yo Greg

I do have a small strategic position in that stock.
Currently there is a proxy fight going at ATLC.
One board member wants to oust the rest of the board.
The rest of the board of course doesn't sit still. They
wanna sack the renegade director, who seems to have backing of one major shareholder but is up against the whole management.
Check out the ATLC thread on Yahoo.A lot of posts being posted which
are worth reading. As for me -I am not sure whether to indulge into
that kind of talk .I'd rather talk science.
Besides antisense , ATLC holds rights to an allegedly revolutionary
new method to remove cataracts called catarex.Bausch&Lomb is developing this method now and is in charge to gain approval.Atlc will get at least 7% royalties. ATLC just doesn't have any exposure on the street.
There aren't a lot people following the stock. I stopped long ago
lamenting the dismal performance of the stock. I look just at the science. Read their papers . They aren't trivial at all.
Today ISIP's the antisense leader. Tomorrow this might very well be
ATLC,if they have sufficient funds to go all the way. If catarex is on the market the $$$ will start to pour in with which they could fund antisense and the rest.
Disclaimer:yes I am optimistic and bullish on this one and reckon with 10 bucks within 12 months due to positive news stream.

Greg what do you think? Are you long this one?